Top Markets
#1 MowCat MowCat +49.36%
#2 Bitway Bitway +26.94%
#3 Velvet Velvet +25.63%
#4 aPriori aPriori +23.81%
#5 OVERTAKE OVERTAKE +18.66%
#6 Fake World Assets Fake World Assets +18.38%
#7 TROLL TROLL +16.87%
#8 Derive Derive +16.36%
#9 Verus Coin Verus Coin +15.91%
#10 Audiera Audiera +14.28%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Rank in Stocks #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Share Price
$0.04895618
Last synced: 2025-03-18
Market Cap
$5.55M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CA
Trade WPD Pharmaceuticals Inc. (WBIO)

Category

Healthcare
Operating Margin for WPD Pharmaceuticals Inc. (WBIO)
Operating Margin as of 2026 TTM: 0.00%
According to WPD Pharmaceuticals Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for WPD Pharmaceuticals Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.